Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Ulisse Biomed Spa
UBMCurrent price
0.91 EUR
-0.002 EUR (-0.22%)
Last closed
0.9 EUR
Company
www.ulissebiomed.com
ISIN
IT0005451213
Sector
Healthcare
Industry
Biotechnology
Exchange
Borsa Italiana
Capitalization
20 455 998 EUR
Yield for 12 month
-47.70 %
1Y
3Y
5Y
10Y
15Y
UBM
Ulisse Biomed S.p.A., a healthcare biotech company, develops, produces, and markets vitro diagnostic medical devices in Italy. The company through its Sagitta platform offers various tests, such as Ladymed/HPV Selfy for the detection of human papillomavirus (HPV); CoronaMelt, a diagnostic test for Sars- CoV-2; CoronaMelt Var, a diagnostic assay for the detection and genotyping of Sars-CoV-2 variants; and UlisseFaster, a reagent for the pre-treatment of biological samples. It provides various tests and reagents for sexually transmitted diseases and HPV. In addition, the company's platforms also comprise NanoHybrid, a platform to detect specific antibodies and protein analytes directly from serum or whole blood; and Aptavir platform to develop and produce synthetic nucleic acid molecules to limit the infectivity of pathogens. Ulisse Biomed S.p.A. was founded in 2015 and is based in Udine, Italy. Address: Via Cavour, 20, Udine, UD, Italy, 33100
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
1.17 EURP/E ratio
–Dividend Yield
–Current Year
+117 591 EUR
Last Year
+137 901 EUR
Current Quarter
+16 076 EUR
Last Quarter
+8 039 EUR
Current Year
-1 491 421 EUR
Last Year
-1 538 408 EUR
Current Quarter
-872 500 EUR
Last Quarter
-253 106 EUR
Key Figures UBM
1 year
3 years
5 years
10 years
EBITDA
-4 705 757 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-15.69 %
PEG Ratio
–
Return On Equity TTM
-28.81 %
Wall Street Target Price
1.17 EUR
Revenue TTM
65 952 EUR
Book Value
1.26 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-33 %
Dividend Yield
–
Gross Profit TTM
-891 316 EUR
Earnings per share
-0.22 EUR
Diluted Eps TTM
-0.22 EUR
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics UBM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History UBM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation UBM
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
155.7011
Price Sales TTM
310.1667
Enterprise Value EBITDA
51.9243
Price Book MRQ
0.7558
Financials UBM
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators UBM
For 52 weeks
0.9 EUR
1.96 EUR
50 Day MA
0.99 EUR
Shares Short Prior Month
–
200 Day MA
1.32 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart